Table 2. Statistical results of the global omnibus ANOVA.
Genotype | 300–500 ms | 500–700 ms |
ADCY8 (A/G v. G/G) | F(3,184) = 0.775, p = 0.494 | F(3,201) = 1.219, p = 0.304 |
APOE (ε2 v. ε3) | F(3,158) = 1.353, p = 0.261 | F(3,160) = 1.560, p = 0.204 |
APOE (ε2 v. ε4) | F(3,91) = 1.88, p = 0.147 | F(3,98) = 1.434, p = 0.239 |
APOE (ε3 v. ε4) | F(3,157) = 0.221, p = 0.867 | F(3,175) = 0.165, p = 0.923 |
BDNF (A Carriers v. G/G) | F(3,226) = 0.181, p = 0.896 | F(3,241) = 0.206, p = 0.889 |
COMT (A/A v. G/G) | F(3,118) = 1.125, p = 0.341 | F(3,111) = 0.319, p = 0.796 |
COMT (A/G v. A/A) | F(2,157) = 0.157, p = 0.895 | F(3,189) = 0.342, p = 0.795 |
COMT (A/G v. G/G) | F(3,162) = 1.112, p = 0.343 | F(3,175) = 1.277, p = 0.284 |
KIBRA (C/C v. T Carriers) | F(3,215) = 0.844, p = 0.463 | F(3,229) = 0.434, p = 0.725 |
PRKACG (C/C v. G Carriers) | F(3,229) = 1.339, p = 0.263 | F(3,242) = 0.362, p = 0.777 |
PRKCA (A Carriers v. G/G) | F(3,224) = 1.261, p = 0.289 | F(3,247) = 3.945, p = 0.008 * |
*Significant differences (p<0.05) are highlighted in bold and starred.